SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001558370-23-006262
Filing Date
2023-04-20
Accepted
2023-04-20 07:00:14
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-04-20

Document Format Files

Seq Description Document Type Size
1 ARS acrs-20221231xars.pdf ARS 2764937
  Complete submission text file 0001558370-23-006262.txt   3809629
Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-37581 | Film No.: 23831366
SIC: 2834 Pharmaceutical Preparations